<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>8(63)</volume><submitter>Vidula N</submitter><journal>Oncotarget</journal><pagination>106167-106168</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5739720</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Targeted therapy for metastatic triple negative breast cancer: The next frontier in precision oncology.</pubmed_title><pmcid>PMC5739720</pmcid><pubmed_authors>Vidula N</pubmed_authors><pubmed_authors>Bardia A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Targeted therapy for metastatic triple negative breast cancer: The next frontier in precision oncology.</name><description/><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Dec</publication><modification>2025-04-04T12:32:13.433Z</modification><creation>2025-04-04T12:32:13.433Z</creation></dates><accession>S-EPMC5739720</accession><cross_references><pubmed>29290935</pubmed><doi>10.18632/oncotarget.22580</doi></cross_references></HashMap>